Media Highlights

Serina announces partnership with Scripps Research Institute

News Outlet: 
The Huntsville Times, al.com
Date published: 
August 9, 2013
HUNTSVILLE, Alabama - Huntsville phamaceutical company Serina Therapeutics has signed an agreement with Scripps Research Institute to develop new cancer drugs using its polymer-based technology. Scripps is a large independent non-profit biomedical research institute with campuses in California and Florida.
 
Serina's proprietary polymer technology will be used to form new "antibody drug conjugates" under the agreement, Serina President and CEO Dr. Randal Moreadith said in an Aug. 6 interview. Antibodies are the body's natural defense mechanisms against infection and disease, and antibody drug conjugates - a method of attaching drugs to antibodies to aim those drugs directly at diseased cells - have moved from theoretical to increasingly possible in recent years. Two new antibody drugs have been announced recently targeting breast cancer and lymphoma.
 

iRepertoire and Sequenta join forces on blood cancer testing

News Outlet: 
Business Wire
Date published: 
August 7, 2013
SOUTH SAN FRANCISCO, Calif. and HUNTSVILLE, Ala. -- Sequenta and iRepertoire announced today that Sequenta has gained exclusive rights to the iRepertoire intellectual property on novel methods of immune cell sequencing for minimal residual disease (MRD) testing. This intellectual property complements Sequenta’s existing patents on MRD, including its proprietary LymphoSIGHT™ technology. The agreement reinforces Sequenta’s patent portfolio, which strengthens Sequenta’s ability to provide future products and new features and solidifies the company’s position as the MRD market leader.
 

Diatherix Laboratories acquires diagnostic testing patent

News Outlet: 
PRNewswire, GenomeWeb Daily News
Date published: 
August 6, 2013
Huntsville, Ala. -- DIATHERIX Laboratories, Inc., today announced that it has acquired the patent to Tem-PCR, a diagnostic testing technology that allows for rapid identification of multiple infectious disease organisms. The acquisition from QIAGEN, a leading global provider of molecular sample and assay technologies, follows a multi-year agreement through which DIATHERIX licensed Tem-PCR from QIAGEN. Terms of the deal were not disclosed.
 

BioTrain interns featured during final poster presentation

News Outlet: 
The Huntsville Times, al.com
Date published: 
July 30, 2013
HUNTSVILLE, Alabama -- Interns as young as 10th grade finished theHudsonAlpha Institute for Biotechnology BioTech program with a poster presentation explaining their research Wednesday afternoon.

New research grant to study childhood genetic disorders featured in local media

News Outlet: 
The Huntsville Times, al.com
Date published: 
July 22, 2013

HUNTSVILLE, Ala. - DNA data from hundreds of North Alabama children and their parents will soon be part of a major new genetic study of childhood diseases led by Huntsville's HudsonAlpha Institute for Biotechnology and including the University of Alabama in Birmingham. The National Institutes of Health announced a $7.6 million research grant Tuesday to the non-profit institute for the study.

R10K, Jian Han featured in Birmingham publication

News Outlet: 
Birmingham Medical News
Date published: 
July 19, 2013
“When something goes wrong, the immune system knows. It diagnoses the problem and tries to treat it,” Jian Han, M.D., Ph.D., said. “We want to learn what the immune system can teach us about improving our ability to diagnose diseases, evaluate the prognosis of patients and manage their treatment.”
 

Business Alabama features Jeremy Schmutz and HudsonAlpha cotton research

News Outlet: 
Business Alabama
Date published: 
June 27, 2013
That Old South anthem “Dixie,” maundering for the “land of cotton,” may well have been picturing Alabama, but certainly not the Alabama cotton fields of the HudsonAlpha Institute for Biotechnology.
 
It’s not “look away” but way ahead that the gene scientists of HudsonAlpha have in mind when they think about cotton.
 

Rick Myers discusses Supreme Court ruling on gene patents

News Outlet: 
The Huntsville Times, al.com
Date published: 
June 16, 2013
HUNTSVILLE, Alabama - Instead of freezing the market for new genetic products, the U.S. Supreme Court's decision that genes cannot be patented will "bring many more creative minds" to genomic research, the head of the HudsonAlpha Institute for Biotechnology said Monday. Genes cannot be patented now, Dr. Rick Myers said, but new drugs, tests and technologies based on DNA research can be. It will be easier for innovators to generate those new products, Myers said, without having to deal with company patents on the genes needed for their work.
 

Nine Madison County teachers participating in GTAC academy

News Outlet: 
The Huntsville Times, al.com
Date published: 
June 16, 2013
HUNTSVILLE, Alabama - Nine teachers from Madison County are among the teachers selected to take part in the Genetic Technologies for Alabama Classrooms teacher academy at the HudsonAlpha Institute for Biotechnology. The two-week program is designed to give teachers the experience and knowledge to teach genetics effectively to their students.
 

The iCell app surpasses 250,000 iTunes downloads

News Outlet: 
al.com
Date published: 
June 10, 2013

HUNTSVILLE, Ala. -- iCell, the interactive app created by the HudsonAlpha Institute for Biotechnology to help students visualize the inside of a typical cell, has just passed 250,000 downloads on iTunes. It's the latest accomplishment for a free app that's making news in the educational world. iCell is also available through the Android and Windows stores and can be viewed at HudsonAlpha's website.

Read the rest of the al.com story here